Astrana Health, Inc. (ASTH) vs Palvella Therapeutics, Inc. (PVLA)
A side-by-side comparison of Astrana Health, Inc. and Palvella Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ASTH
Astrana Health, Inc.
$37.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
PVLA
Palvella Therapeutics, Inc.
$128.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ASTH vs PVLA
growth of $100 · dividends reinvested · last 2yASTH -6.7% (-3.4%/yr)PVLA +677.4% (+178.8%/yr)PVLA compounded faster over this window
Log scale — wide-divergence pair
ASTH PVLA
ASTH vs PVLA: by the numbers
- •PVLA is the larger company ($1.84B vs $1.83B market cap).
- •ASTH is profitable (1.05% net margin) while PVLA runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | ASTH | PVLA |
|---|---|---|
| P/E ratio | 45.26 | N/A |
| Forward P/E | 26.47 | N/A |
| P/S ratio | 0.48 | N/A |
| P/B ratio | 2.21 | 8.47 |
| EV / EBITDA | 13.48 | N/A |
| FCF yield | 8.64% | N/A |
Profitability
| Metric | ASTH | PVLA |
|---|---|---|
| Gross margin | 9.22% | 0.00% |
| Operating margin | 2.61% | 0.00% |
| Net margin | 1.05% | 0.00% |
| ROE | 4.88% | -28.45% |
| ROIC | 4.13% | -23.90% |
Growth (annualized)
| Metric | ASTH | PVLA |
|---|---|---|
| Revenue CAGR (5Y) | 53.77% | N/A |
| EPS CAGR (5Y) | -15.06% | N/A |
| FCF CAGR (5Y) | 18.35% | N/A |
| Total return CAGR (5Y) | -16.52% | N/A |
Frequently asked
- Is ASTH or PVLA more profitable?
- ASTH runs the higher net margin — ASTH at 1.05% versus PVLA at 0.00%.
Go deeper
Dig into the metrics
Astrana Health P/E ratioAstrana Health ROEPalvella Therapeutics ROEAstrana Health operating marginPalvella Therapeutics operating marginAstrana Health revenue growthPalvella Therapeutics revenue growthAstrana Health free cash flowPalvella Therapeutics free cash flow
Astrana Health & Palvella Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.